Hagiwara K, Sato K, Takahashi K, Shishido M, Awano N, Abe Y, Nagata K, Ohana N, Hoshino S
Department of Cardiovascular Surgery, Ohara Medical Center, Fukushima, Japan.
Kyobu Geka. 1995 Oct;48(11):925-8.
Two cases of CA 19-9 producing pulmonary papillary adenocarcinoma were reported. Pathological examination showed a well differentiated papillary adenocarcinoma with partially bronchiolo-alveolar cell type. Immunohistochemical study showed a positive straining for CA 19-9 on tumor cells. The level of CA 19-9 decreased after lobectomy and anti-cancer chemotherapy using CDDP and VDS. The series of CA 19-9 level is very useful to evaluate the effect of surgery and chemotherapy. Also it is useful to find out the recurrence of carcinoma.
报告了2例产生CA 19-9的肺乳头状腺癌病例。病理检查显示为高分化乳头状腺癌，部分为细支气管肺泡细胞型。免疫组织化学研究显示肿瘤细胞上CA 19-9染色阳性。使用顺铂和长春地辛进行肺叶切除和抗癌化疗后，CA 19-9水平下降。CA 19-9水平系列对于评估手术和化疗效果非常有用。对于发现癌症复发也很有用。
